| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,023 |
3,190 |
$219K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,234 |
769 |
$40K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
287 |
211 |
$21K |
| 99199 |
Unlisted special service, procedure or report |
4,599 |
4,588 |
$14K |
| 80305 |
|
1,655 |
1,045 |
$10K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
268 |
196 |
$7K |
| 96127 |
|
1,190 |
892 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
270 |
109 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
20 |
18 |
$1K |
| 94760 |
|
1,736 |
1,306 |
$879.75 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
16 |
15 |
$695.23 |
| 81003 |
|
954 |
585 |
$559.84 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
42 |
25 |
$415.44 |
| 82962 |
|
621 |
310 |
$415.27 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
28 |
25 |
$227.54 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
21 |
12 |
$156.70 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
18 |
16 |
$155.43 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
22 |
12 |
$106.40 |
| 81002 |
|
241 |
109 |
$99.82 |
| 90686 |
|
24 |
13 |
$41.34 |
| 36416 |
|
322 |
192 |
$0.00 |